1. Human papillomavirus vaccination coverage among adolescent girls, 2007–2012, and postlicensure vaccine safety monitoring, 2006–2013 – United States;Centers for Disease Control and Prevention;MMWR Morbidity Mortality Weekly Report,2013
2. Recommendations on the use of quadrivalent human papillomavirus vaccine in males–Advisory Committee on Immunization Practices (ACIP), 2011;Centers for Disease Control and Prevention;MMWR Morbidity Mortality Weekly Report,2011
3. Use of a 2-dose schedule for human papillomavirus vaccination - updated recommendations of the advisory committee on immunization practices;Meites;MMWR Morbidity Mortality Weekly Report,2016
4. Centers for disease C, prevention. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.;Petrosky;MMWR Morbidity Mortality Weekly Report,2015
5. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010;Markowitz;J Infect Dis,2013